Therefore, we concluded that D2 and NANOG are specifically expressed in the tumor epithelium of BCC and not in the CD34+ population of CSCs and that the expression of D2 and NANOG in CSCs drastically differs from that in the bulk of tumors. This evidence concerns the gene DIO2 and skin basal cell carcinoma.